Tag: USA
Arthur J. Gallagher acquires personal lines-focused Denver Agency
Arthur J. Gallagher & Co. has acquired Denver Agency, a personal lines-focused insurance agency based in Denver, Colorado, for an undisclosed price. Established in 1932, ... Read More
Hub buys trade credit insurance brokerage Intercontinental Growth Strategies
Hub International said that it has acquired the assets of Intercontinental Growth Strategies (IGS), a Chicago-based trade credit insurance brokerage for an undisclosed price. Intercontinental ... Read More
Eastern Insurance acquires John T. Burns Insurance Agency in Massachusetts
Eastern Insurance Group, a fully-owned subsidiary of Boston-based Eastern Bank, has acquired the operating assets of the John T. Burns Insurance Agency, an insurance agency ... Read More
Pfizer to acquire Oxbryta developer Global Blood Therapeutics for $5.4bn
Pfizer has agreed to acquire Global Blood Therapeutics (GBT), a publicly-listed American biopharma company, in a deal worth around $5.4 billion with an aim to ... Read More
BorgWarner snaps up Rhombus Energy Solutions in deal worth up to $185m
BorgWarner, an American automotive supplier listed on the New York Stock Exchange (NYSE), has acquired Rhombus Energy Solutions, in a deal worth up to $185 ... Read More
Marker Therapeutics gets FDA approval for MT-601 IND in r/r NHL
Marker Therapeutics said that the US Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for MT-601 for the treatment of ... Read More
Vaxcyte gets FDA fast track designation for PCV candidate VAX-24
Vaxcyte has secured fast track designation for VAX-24, its 24-valent pneumococcal conjugate vaccine (PCV) candidate, from the US Food and Drug Administration (FDA) for the ... Read More
Marpai to acquire employee health and benefits TPA Maestro Health
Marpai, a US-based insurtech company, has agreed to acquire Maestro Health, a third-party administrator (TPA) for employee health and benefits, for $22.1 million in cash. ... Read More
AstraZeneca, Daiichi Sankyo get Enhertu FDA approval for HER2-low metastatic breast cancer
Enhertu FDA approval : AstraZeneca and Daiichi Sankyo have secured approval for Enhertu (trastuzumab deruxtecan) from the US Food and Drug Administration for the treatment ... Read More
Carlyle, GIC invest in green ammonia project developer Eneus Energy
Eneus Energy Limited, a green ammonia project development company, has secured an undisclosed investment from Carlyle and Singaporean sovereign wealth fund GIC. The investment is ... Read More
